Bank of Montreal Can Buys 9,288 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Bank of Montreal Can increased its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 16.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 65,263 shares of the real estate investment trust’s stock after acquiring an additional 9,288 shares during the quarter. Bank of Montreal Can’s holdings in Omega Healthcare Investors were worth $2,235,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Cutter & CO Brokerage Inc. increased its position in Omega Healthcare Investors by 3.7% during the second quarter. Cutter & CO Brokerage Inc. now owns 8,206 shares of the real estate investment trust’s stock worth $281,000 after acquiring an additional 290 shares during the period. Left Brain Wealth Management LLC increased its position in Omega Healthcare Investors by 2.0% during the fourth quarter. Left Brain Wealth Management LLC now owns 17,365 shares of the real estate investment trust’s stock worth $532,000 after acquiring an additional 335 shares during the period. Pasadena Private Wealth LLC increased its position in Omega Healthcare Investors by 2.9% during the second quarter. Pasadena Private Wealth LLC now owns 12,049 shares of the real estate investment trust’s stock worth $413,000 after acquiring an additional 335 shares during the period. Bay Colony Advisory Group Inc d b a Bay Colony Advisors increased its position in Omega Healthcare Investors by 4.7% during the second quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 7,574 shares of the real estate investment trust’s stock worth $259,000 after acquiring an additional 342 shares during the period. Finally, Tidal Investments LLC increased its position in Omega Healthcare Investors by 2.5% during the first quarter. Tidal Investments LLC now owns 14,325 shares of the real estate investment trust’s stock worth $454,000 after acquiring an additional 348 shares during the period. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Down 0.2 %

Shares of NYSE:OHI opened at $39.98 on Friday. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $41.53. The company has a debt-to-equity ratio of 1.19, a quick ratio of 5.79 and a current ratio of 5.79. The company’s fifty day moving average is $39.04 and its 200-day moving average is $34.55. The company has a market capitalization of $10.31 billion, a PE ratio of 36.02, a P/E/G ratio of 1.30 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). The company had revenue of $252.70 million for the quarter, compared to analyst estimates of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm’s quarterly revenue was up 17.5% on a year-over-year basis. During the same quarter last year, the company earned $0.74 EPS. Equities research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were given a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 5th. This represents a $2.68 annualized dividend and a yield of 6.70%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 241.44%.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on OHI shares. Scotiabank boosted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their price target for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Wells Fargo & Company reissued an “overweight” rating and issued a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday. Finally, Truist Financial boosted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $36.00.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.